These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35574600)

  • 1. Identification of SAA1 as a prognostic biomarker associated with immune infiltration in glioblastoma.
    Cui G; Xiao Y
    Autoimmunity; 2022 Sep; 55(6):418-427. PubMed ID: 35574600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SAA1 Expression as a Potential Prognostic Marker of the Tumor Microenvironment in Glioblastoma.
    Cao K; Jiang X; Wang B; Ni Z; Chen Y
    Front Neurol; 2022; 13():905561. PubMed ID: 35756918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel prognostic targets in glioblastoma using bioinformatics analysis.
    Yin X; Wu Q; Hao Z; Chen L
    Biomed Eng Online; 2022 Apr; 21(1):26. PubMed ID: 35436915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SAA1 Has Potential as a Prognostic Biomarker Correlated with Cell Proliferation, Migration, and an Indicator for Immune Infiltration of Tumor Microenvironment in Clear Cell Renal Cell Carcinoma.
    Xu Z; Wu Y; Fu G; Chen X; Sun J; Tian J; Jiang P; Wang Y; Jin B
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum amyloid A1 in combination with integrin αVβ3 increases glioblastoma cells mobility and progression.
    Lin CY; Yang ST; Shen SC; Hsieh YC; Hsu FT; Chen CY; Chiang YH; Chuang JY; Chen KY; Hsu TI; Leong WC; Su YK; Lo WL; Yeh YS; Patria YN; Shih HM; Chang CC; Chou SY
    Mol Oncol; 2018 May; 12(5):756-771. PubMed ID: 29603594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
    Tian QS; Zhang Q; Huang W
    Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Single-cell transcriptome analysis of multigrade glioma heterogeneity and immune microenvironment revealed potential prognostic biomarkers].
    Liu J; Xu K; Ma L; Wang Y
    Sheng Wu Gong Cheng Xue Bao; 2022 Oct; 38(10):3790-3808. PubMed ID: 36305410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction and analysis of hub genes between glioblastoma and low-grade glioma using bioinformatics analysis.
    Xu B
    Medicine (Baltimore); 2021 Jan; 100(3):e23513. PubMed ID: 33545929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 63 signature genes prediction system is effective for glioblastoma prognosis.
    Zhang Y; Xu J; Zhu X
    Int J Mol Med; 2018 Apr; 41(4):2070-2078. PubMed ID: 29393370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune infiltration-associated serum amyloid A1 predicts favorable prognosis for hepatocellular carcinoma.
    Zhang W; Kong HF; Gao XD; Dong Z; Lu Y; Huang JG; Li H; Yang YP
    World J Gastroenterol; 2020 Sep; 26(35):5287-5301. PubMed ID: 32994688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Analysis of CD163 as a Prognostic Biomarker and Associated with Immune Infiltration in Glioblastoma Multiforme.
    Li H; Wang D; Yi B; Cai H; Xi Z; Lou X; Li Z
    Biomed Res Int; 2021; 2021():8357585. PubMed ID: 34395626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microrna-1224-5p Is a Potential Prognostic and Therapeutic Biomarker in Glioblastoma: Integrating Bioinformatics and Clinical Analyses.
    Wei X; Zhang QM; Liu C; Wu S; Nong WX; Ge YY; Lin LN; Li F; Xie XX; Luo B
    Curr Med Sci; 2022 Jun; 42(3):584-596. PubMed ID: 35678909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PBK as a Potential Biomarker Associated with Prognosis of Glioblastoma.
    Dong C; Fan W; Fang S
    J Mol Neurosci; 2020 Jan; 70(1):56-64. PubMed ID: 31617063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-omics analysis predicts fibronectin 1 as a prognostic biomarker in glioblastoma multiforme.
    Kabir F; Apu MNH
    Genomics; 2022 May; 114(3):110378. PubMed ID: 35513291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the key prognostic genes and potential traditional Chinese medicine therapeutic targets in glioblastoma based on bioinformatics and network pharmacology methods.
    Xia Z; Gao P; Chen Y; Shu L; Ye L; Cheng H; Dai X; Hu Y; Wang Z
    Transl Cancer Res; 2022 May; 11(5):1386-1405. PubMed ID: 35706800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between SNAP25 and human glioblastoma multiform: a comprehensive bioinformatic analysis.
    Yu C; Yin J; Wang X; Chen L; Wei Y; Lu C; You Y
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32412599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
    Chen X; Pan Y; Yan M; Bao G; Sun X
    Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of gene biomarkers and immune cell infiltration characteristics in rectal cancer.
    Wen L; Han Z; Du Y
    J Gastrointest Oncol; 2021 Jun; 12(3):964-980. PubMed ID: 34295549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a key glioblastoma candidate gene, FUBP3, based on weighted gene co-expression network analysis.
    Li J; Zhang Z; Guo K; Wu S; Guo C; Zhang X; Wang Z
    BMC Neurol; 2022 Apr; 22(1):139. PubMed ID: 35413821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.